Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|July 17, 2023
Combining Immunotherapy with Transarterial RadioembolizationZeynep Ceren Balaban Genc, Efe Soydemır, Seval Ay Ersoy, et al.Journal of Clinical Medicine|January 10, 2026
Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in mHSPC Patients Treated with Abiraterone or EnzalutamideUgur Ozkerim, Oguzcan Kinikoglu, Deniz Isik, et al.Journal of Clinical Medicine|January 28, 2026
Adjuvant Chemotherapy and Chemoradiotherapy in Gastric Cancer: Prognostic Determinants and Real-World Survival OutcomesSedat Yildirim, Hatice Odabas, Seval Ay Ersoy, et al.Journal of Clinical Medicine|October 16, 2025
Triple-Negative Apocrine Carcinoma: Largest Cohort Highlights Unique Biology and Survival AdvantageTugba Basoglu, Ugur Ozkerim, Sila Oksuz, et al.Journal of Clinical Medicine|February 27, 2026
Association Between Body Mass Index and Clinical Outcomes of CDK4/6 Inhibitors in HR+/HER2- Metastatic Breast Cancer: A Real-World Cohort StudySeval Orman, Miray Aydoğan, Nisanur Sarıyar Busery, et al.Medicina (Kaunas, Lithuania)|October 29, 2025
The Effect of the Clinical-Pathological CPS+EG Staging System on Survival Outcomes in Patients with HER2-Positive Breast Cancer Receiving Neoadjuvant Treatment: A Retrospective StudySeval Orman, Miray Aydoğan, Oğuzcan Kınıkoğlu, et al.Journal of Clinical Medicine|January 10, 2026
Prognostic Impact of Tumor Size in Patients with Stage T3N1 Colon CancerEzgi Turkoglu, Nisanur Sarıyar Busery, Sedat Yildirim, et al.Medicina (Kaunas, Lithuania)|June 27, 2025
The Association of Khorana Risk Score with Venous Thromboembolism and Overall Survival in Patients with Metastatic Gastric CancerEzgi Turkoglu, Goncagul Akdag Topal, Sedat Yıldırım, et al.Scientific Reports|July 15, 2026
Maintenance pemetrexed after platinum pemetrexed chemotherapy and survival outcomes in malignant pleural mesothelioma in a multicenter real world studyOkan Aydin, Zehra Sucuoglu Isleyen, Mert Erciyestepe, et al.Clinical Medicine Insights. Oncology|May 14, 2026
Prognostic Impact and Clinicopathological Correlates of HER2 Status in Gastric Cancer: A Multicenter Retrospective Turkish Oncology Group StudySedat Yildirim, Ozlem Nuray Sever, Ezgi Turkoglu, et al.Pageof 2